Syngenta ordered to pay millions over GM corn

(Reuters) — A U.S. jury has ordered Syngenta AG to pay $217.7 million to more than 7,000 Kansas farmers over its decision to commercialize a genetically modified strain of corn before China approved importing it.

Today’s verdict by a federal jury in Kansas City, Kansas, was announced by lawyers for the farmers, who blamed the Swiss company for causing catastrophic damage to them after Chinese officials began refusing U.S. corn shipments in 2013.

Their case was the first to go to trial. Thousands of other corn producers and traders are also seeking damages over China’s non-approval of the company’s corn seeds for importation.

Lawyers for the corn producers said in a statement that the verdict was “only the beginning.” They have claimed that damages for farmers nationally totalled $5.77 billion, according to court papers.

Syngenta said it will appeal the verdict, which included only compensatory damages and no punitive damages.

“We are disappointed with today’s verdict because it will only serve to deny American farmers access to future technologies even when they are fully approved in the U.S.,” Syngenta said in a statement.

Syngenta began selling a strain of insect-resistant GM corn called Agrisure Viptera in the United States in 2010. It started selling a second strain called Agrisure Duracade in 2013.

In their lawsuit, the Kansas corn farmers accused Syngenta of negligently commercializing the corn seeds before obtaining export approval in China, a major importer.

In 2013, Chinese officials detected Viptera in U.S. corn shipments. The country began rejecting shipments containing millions of tonnes of U.S. corn because they contained the strain, which was unapproved for import, the farmers said.

Nearly 90 percent of corn in the United States is now genetically modified, according to the U.S. Department of Agriculture.

The loss of the Chinese market caused U.S. corn prices to plummet, leading to more than $5 billion in losses for corn producers, the farmers’ lawyers said. China did not approve Viptera until December 2014, while Duracade is still pending approval.

Syngenta denied wronging. It said at the time that no company had ever delayed launching a U.S. approved corn product in the U.S. just because China had yet to approve its import.

It also said the decline in sales to China was offset by exports to other countries.

About the author

Comments

explore

Stories from our other publications